| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $385.1M | +8.7% |
| R&D Expense | $37.1M | +8.6% |
| SG&A Expense | $94.2M | -1.2% |
| Operating Income | -$1.7M | +95.8% |
| Pre-tax Income | -$17.2M | +68.8% |
| Income Tax | -$5.1M | -2498.6% |
| Net Income | -$12.1M | +78.2% |
| EPS (Basic) | -$0.08 | +77.1% |
| EPS (Diluted) | -$0.08 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $179.2M | -23.7% |
| Accounts Receivable | $90.6M | +20.2% |
| Current Assets | $310.9M | -8.6% |
| Total Assets | $1.58B | +0.8% |
| Current Liabilities | $146.1M | +12.4% |
| Long-term Debt | $295.4M | +1.4% |
| Total Liabilities | $516.4M | +0.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $80.5M | -2.8% |
| Capital Expenditures | $1.6M | -8.6% |
| Investing Cash Flow | -$112.4M | -41.3% |
| Financing Cash Flow | -$21.0M | -122.4% |
| Free Cash Flow | $78.8M | -2.6% |
| +77.1% |
| Stockholders' Equity |
| $1.06B |
| +1.1% |